Schedule 13G ownership disclosure
Armata Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 04216R102
Event date: 2019-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 990,643
- Percent of class
- 9.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-025339
- Form type
- SC 13G
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- May 10, 2019
- Reporting period
- May 09, 2019
- Description
- Schedule 13G beneficial ownership